NY-ESO-1 is a human tumor antigen of the cancer/testis family. It is highly expressed in many poor-prognosis melanomas.
It is being studied as possible target for a cancer vaccine or immunotherapy.
It is a target for some experimental engineered T-cell therapies for myeloma.